IP Library Granted Patent US 8,420,666
Granted Patent B2
US 8,420,666 · App. 12/531,043 · Granted Apr 16, 2013

Pyrazolo (3, 4-B) pyridine derivatives as phosphodiesterase inhibitors

Inventors: Sonali Rudra (Gurgaon, IN); Nidhi Gupta (New Delhi, IN); Lalit Kumar Baregama (Chittorgarh, IN); Ritu Agarwal (Hooghly, IN); Vinayak Vasantrao Khairnar (Nashik, IN); Mandadapu Raghu Ramaiah (Guntur, IN); Venkata P. Palle (Pune, IN); Sarala Balachandran (Mumbai, IN); Atul Kondaskar (Nagpur, IN); Manohar Salla (Gurgaon, IN); Abhijit Ray (New Delhi, IN); Sunanda G. Dastidar (New Delhi, IN); Lalitha Vijaykrishnan (New Delhi, IN)
Assignee: Ranbaxy Laboratories Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,420,666
App. No.
12/531,043
Granted
Apr 16, 2013
Kind
B2
Abstract

The present invention relates to phosphodiesterase (PDE) type 4, phosphodiesterase (PDE) type 7 and dual PDE type 4/PDE type 7 inhibitors. Compounds disclosed herein having the structure of Formula 1: can be useful in the treatment, prevention, inhibition or suppression of CNS diseases, for example, multiple sclerosis; various pathological conditions such as diseases affecting the immune system, including AIDS, rejection of transplant, auto-immune disorders such as T-cell related diseases, for example, rheumatoid arthritis; inflammatory diseases such as respiratory inflammation diseases including chronic obstructive pulmonary disease (COPD), asthma, bronchitis, allergic rhinitis, adult respiratory distress syndrome (ARDS) and other inflammatory diseases including but not limited to psoriasis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis; gastrointestinal inflammation diseases such as Crohn's disease, colitis, pancreatitis as well as different types of cancers including leukaemia; especially in humans. Processes for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds and their use as PDE type 4, PDE type 7 and dual PDE type 4/PDE type 7 inhibitors are provided.

Claims (346)

1. A compound having the structure of Formula I:

or its pharmaceutically acceptable salts, wherein

R 1 and R 2 independently are hydrogen, aryl, heteroaryl, —COR 4 , —S(O) m R 4 (wherein R 4 is hydrogen, alkyl, cycloalkyl, aryl, aralkyl, heteroaryl or heterocyclyl and m is an integer from 0-2),

 wherein X is —O—, S(O) m (wherein m is an integer from 0-2), C(═O), C═NOH, CR f R q (wherein R f and R q independently are hydrogen, hydroxy, carboxy or cyano) or NR 5 {wherein R 5 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocyclyl, —COR 4 , —S(O) m R 4 , —COOR 4 or —CONR 4 R′ 4 (wherein R 4 and R′ 4 independently are hydrogen, alkyl, cycloalkyl, aryl, aralkyl, heteroaryl or heterocyclyl and m is an integer from 0-2)};

R 3 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, aryl, aralkyl, aralkenyl, cycloalkylalkyl, heterocyclyl, heteroaryl, heterocyclylalkyl or heteroarylalkyl;

M is a 3-7 membered saturated, partially saturated or unsaturated ring containing carbon atoms wherein one or more carbon atoms optionally are replaced by heteroatoms selected from O, S(O) m {wherein m is an integer from 0-2} or NR 6 {wherein R 6 is hydrogen, alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocyclyl, —COR 4 , —S(O) m R 4 , —COOR 4 or —CONR 4 R′ 4 (wherein R 4 and R′ 4 independently are hydrogen, alkyl, cycloalkyl, aryl, aralkyl, heteroaryl or heterocyclyl and m is an integer from 0-2)}, or one or more carbon atoms optionally are substituted with oxo, halogen, spiro-attached heterocyclyl, hydroxy, cyano, alkyl, heteroaryl, heteroarylalkyl, —(CH 2 ) m NR 4 R′ 4 , —(CH 2 ) m OR 4 , —(CH 2 ) m CONR 4 R′ 4 , —(CH 2 ) m NR 4 COR 4 , or —(CH 2 ) m COOR 4 (wherein m, R 4 and R′ 4 are the same as defined above).

2. A compound, which is selected from

N-cyclohexyl-1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 1),

N-cyclohexyl-1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 2),

N-cyclohexyl-1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 3),

N-cyclohexyl-1-ethyl-5-(1-oxa-7-thia-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 4),

N-cyclohexyl-1-ethyl-5-(7-oxido-1-oxa-7-thia-2-azaspiro[4.4]non-2-en-3-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 5),

N-cyclohexyl-1-ethyl-5-(5-oxa-2-thia-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 6),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 7),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 8),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 9),

4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanol (Compound No. 10),

4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanol (Compound No. 11),

N-cyclohexyl-5-(1,7-dioxa-2-azaspiro[4.4]non-2-en-3-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 12),

4-{[1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanol (Compound No. 13),

N-cyclohexyl-5-(2,2-dioxido-5-oxa-2-thia-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 14),

tert-Butyl 3-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2,8-diazaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 15),

4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanone (Compound No. 16),

4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanone oxime (Compound No. 17),

N-cyclohexyl-1-ethyl-5-(1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine hydrochloride salt (Compound No. 18),

4-{[1-Ethyl-5-(1,9,12-trioxa-2-azadispiro[4.2.4.2]tetradec-2-en-3-yl)-1H -pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanol (Compound No. 19),

4-{[1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanone (Compound No. 20),

4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanone (Compound No. 21),

3-{1-Ethyl-4-[(4-hydroxycyclohexyl)amino]-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-en-8-one (Compound No. 22),

N-cyclohexyl-5-[8-(2,2-dimethylpropanoyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 23),

N-cyclohexyl-1-ethyl-5-{8-[(trifluoromethyl)sulfonyl]-1-oxa-2,8-diazaspiro[4.5]dec -2-en-3-yl}-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 24),

N-cyclohexyl-1-ethyl-5-[8-(ethyl sulfonyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 25),

N-cyclohexyl-5-[8-(cyclopropylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 26),

5-(8-Acetyl-1-oxa-2,8-diazaspiro[4.5]dec-2-en-3-yl)-N-cyclohexyl-1-ethyl-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 27),

N-cyclohexyl-5-(2,5-dioxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 28),

1-(4-Methoxybenzyl)-N-(3-methoxyphenyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 41),

(cis or trans) 3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 42),

(trans or cis) 3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 43),

5-[2-(Benzyloxy)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 44),

(cis or trans) 3-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 45),

3-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-one (Compound No. 46),

7-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile (Compound No. 47),

7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile (Compound No. 48),

5-(5-Oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 49),

1-Methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 50),

5-(1-Oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 51),

1-Ethyl-N-[1-(methylsulfonyl)piperidin-4-yl]-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 52),

N-(1-acetylpiperidin-4-yl)-1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 53),

N-(1-acetylpiperidin-4-yl)-1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 54),

1-(4-Methoxybenzyl)-N-(tetrahydro-2H-pyran-4-yl)-5-(1,9,12-trioxa-2-azadispiro[4.2.4.2]tetradec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 55),

5-(5-Oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 56),

7-[1-(4-Methoxybenzyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile (Compound No. 57),

1-(Cyclopropylmethyl)-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H -pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 58),

1-Butyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 59),

1-(1-Methylethyl)-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 60),

5-(5-Oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-propyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 61),

5-(1-Oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1-(2,2,2-trifluoroethyl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 62),

N-(1-Cyclopentylpiperidin-4-yl)-1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 63),

N-(1-butylpiperidin-4-yl)-1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-107 pyrazolo[3,4-b]pyridin-4-amine (Compound No. 64),

2-(4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}piperidin-1-yl)ethanol (Compound No. 65),

N-[1-(cyclopropylmethyl)piperidin-4-yl]-1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 66),

1-Ethyl-N-[1-(1-methylethyl)piperidin-4-yl]-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 67),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(1-propylpiperidin-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 68),

N-(1-cyclopentylpiperidin-4-yl)-1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 69),

1-Ethyl-N-[1-(1-methylethyl)piperidin-4-yl]-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 70),

1-Cyclopentyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 71),

1-(Cyclopropylmethyl)-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H -pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 72),

1-(1-Methylethyl)-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl) -1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 73),

5-(1-Oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-propyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 74),

1-Cyclopentyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 75),

1-(Cyclopropylmethyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-131 pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 76),

1-(1-Methylethyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 77),

5-(1-Oxa-2-azaspiro[4.4]non-2-en-3-yl)-1-propyl-N-(tetrahydro-2H-pyran-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 78),

1-Methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 79),

N-Cyclohexyl-1-ethyl-5-(1,9,12-trioxa-2-azadispiro[4.2.4.2]tetradec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 80),

3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-one (Compound No. 81),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-piperidin-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 82),

Tert-butyl 4-{[1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}piperidine-1-carboxylate (Compound No. 83),

1-Ethyl-N-(1-ethylpiperidin-4-yl)-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 84),

1-Ethyl-N-(1-methylpiperidin-4-yl)-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 85),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-piperidin-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 86),

Tert-butyl 4-{[1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}piperidine-1-carboxylate (Compound No. 87),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(1-propylpiperidin-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 88),

N-[1-(cyclopropylmethyl)piperidin-4-yl]-1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 89),

2-(4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}piperidin-1-yl)ethanol (Compound No. 90),

N-cyclohexyl-1-(4-methoxybenzyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 91),

3-[1-(4-Methoxybenzyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-one (Compound No. 92),

7-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol (Compound No. 93),

1-Ethyl-N-(3-methoxyphenyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 94),

(cis or trans) 3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 95),

(trans or cis) 3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 96),

5-{2-[(Benzyloxy)methyl]-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl}-1-(4-methoxybenzyl) -N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 97),

(trans or cis) 3-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 98),

7-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid (Compound No. 99),

1-(4-Methoxybenzyl)-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 100),

5-(1-Oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 101),

1-(4-Methoxybenzyl)-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 102),

5-{2-[(Benzyloxy)methyl]-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl}-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 103),

{7-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}methanol (Compound No. 104),

7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid (Compound No. 105),

cis or trans 7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 106),

(trans or cis) 7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 107),

(cis or trans) 3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 108),

(trans or cis) 3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 109),

1-(4-Methoxybenzyl)-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 110),

5-[2-(Benzyloxy)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-(4-methoxybenzyl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 111),

Ethyl (cis or trans) 3-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 112),

Ethyl (trans or cis) 3-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 113),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine ((Compound No. 114),

3-{[1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 115),

3-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 116),

3-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 117),

3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carbonitrile (Compound No. 118),

3-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 119),

3-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carbonitrile (Compound No. 120),

7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol (Compound No. 121),

7-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol (Compound No. 122),

7-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 123),

7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-methyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 124),

7-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-methyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 125),

7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 126),

N-Ethyl-7-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 127),

5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 128),

5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-cyclohexyl-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 129),

N-{7-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}acetamide (Compound No. 130),

N-{7-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}acetamide (Compound No. 131),

4-{[1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 132),

4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 133),

4-{[1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 134),

4-{[5-(2-Cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 135),

1-Ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 136),

1-Ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 137),

1-Ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 138),

7-[1-Ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile (Compound No. 139),

N-Cyclohexyl-1-ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 140),

7-[4-(Cyclohexylamino)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile (Compound No. 141),

3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-methyl-1-oxa-2-azaspiro[4.5]dec-2-en-8-amine (Compound No. 142),

4-{[5-(2-Cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 143),

4-{[1-Ethyl-5-(2-hydroxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 144),

4-{[1-Ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 145),

4-{[1-Ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 146),

4-{[1-Ethyl-5-(8-hydroxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 147),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 148),

3-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 149),

4-{[5-(8-Carbamoyl-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 150),

3-{[5-(8-Carbamoyl-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-1H-pyrazolo[3,4-b.]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 151),

3-{1-Ethyl-4-[(3-hydroxycyclobutyl)amino]-1H-pyrazolo[3,4-b]pyridin-5-yl}-N-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 152),

3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 153),

3-[1-Ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 154),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-N-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 155),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-N-methyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 156),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 157),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 158),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 159),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 160),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 161),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 162),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 163),

3-{-4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 164),

3-[1-Ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 165),

3-[1-Ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 166),

3-[1-Ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carbonitrile (Compound No. 167),

7-[1-Ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid (Compound No. 168),

7-[1-Ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol (Compound No. 169),

7-[1-Ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 170),

5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methyl-N-(tetrahydro-2H -pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 171),

3-[4-(Cyclohexylamino)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-ol (Compound No. 172),

3-[4-(Cyclohexylamino)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carbonitrile (Compound No. 173),

3-[4-(Cyclohexylamino)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 174),

7-[4-(Cyclohexylamino)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid (Compound No. 175),

7-[4-(Cyclohexylamino)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-ol (Compound No. 176),

7-[4-(Cyclohexylamino)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-methyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 177),

5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-cyclohexyl-1-ethyl-3-methyl-1H -pyrazolo[3,4-b]pyridin-4-amine (Compound No. 178),

4-{[1-Ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 179),

4-{[1-Ethyl-5-(8-hydroxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 180),

3-{[1-Ethyl-3-methyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 181),

3-{[1-Ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 182),

3-{[1-Ethyl-3-methyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 183),

3-{[5-(2-Cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 184),

3-{[5-(2-Cyano-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methyl-1H-pyrazolo [3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 185),

3-{[1-Ethyl-5-(8-hydroxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 186),

3-{[1-Ethyl-5-(8-hydroxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 187),

3-{[1-Ethyl-5-(2-hydroxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 188),

3-{[1-Ethyl-5-(2-hydroxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 189),

5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 190),

5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 191),

N-(7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl)acetamide (Compound No. 192),

N-(7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl)acetamide (Compound No. 193),

N-(7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl)propanamide (Compound No. 194),

N-(7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl)propanamide (Compound No. 195),

3-{[5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 196),

3-{[5-(2-Amino-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclobutanecarboxylic acid (Compound No. 197),

3-({5-[2-(Acetylamino)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclobutanecarboxylic acid (Compound No. 198),

3-({5-[2-(Acetylamino)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclobutanecarboxylic acid (Compound No. 199),

3-({1-Ethyl-5-[2-(propanoylamino)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclobutanecarboxylic acid (Compound No. 200),

3-({1-Ethyl-3-methyl-5-[2-(propanoylamino)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H -pyrazolo[3,4-b]pyridin-4-yl}amino)cyclobutanecarboxylic acid (Compound No. 201),

N-ethyl-7-[1-ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b)]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 202),

N-{7-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}propanamide (Compound No. 203),

N-{7-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}propanamide (Compound No. 204),

N-{7-[1-ethyl-3-methyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}propanamide (Compound No. 205),

4-{[5-(8-Amino-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 206),

4-{[5-(8-Amino-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 207),

4-({5-[8-(Acetylamino)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 208),

4-({5-[8-(Acetylamino)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 209),

4-({1-Ethyl-3-methyl-5-[8-(propanoylamino)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 210),

4-({1-Ethyl-5-[8-(propanoylamino)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 211),

7-{4-[(4-Carboxycyclohexyl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid (Compound No. 212),

7-{4-[(4-Carboxycyclohexyl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid (Compound No. 213),

4-{[5-(2-Carbamoyl-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 214),

4-{[5-(2-Carbamoyl-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 215),

4-({1-Ethyl-3-methyl-5-[2-(methylcarbamoyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 216),

4-({1-Ethyl-5-[2-(methylcarbamoyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 217),

4-({1-Ethyl-5-[2-(ethylcarbamoyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 218),

4-({1-Ethyl-5-[2-(ethylcarbamoyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-3-methyl-1H-pyrazolo [3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 219),

3-{4-[(4-Carboxycyclohexyl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 220),

3-{4-[(4-Carboxycyclohexyl)amino]-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylic acid (Compound No. 221),

4-{[5-(8-Carbamoyl-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-3-methyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 222),

4-({1-Ethyl-5-[8-(methylcarbamoyl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 223),

4-({1-Ethyl-3-methyl-5-[8-(methylcarbamoyl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 224),

4-({1-Ethyl-5-[8-(ethylcarbamoyl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-3-methyl-1H -pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 225),

4-({1-Ethyl-5-[8-(ethylcarbamoyl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 226),

4-{[1-Ethyl-5-(8-methoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 227),

4-{[5-(8-Ethoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}cyclohexanecarboxylic acid (Compound No. 228),

4-({1-Ethyl-5-[8-(2-hydroxyethoxy)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-yl}amino)cyclohexanecarboxylic acid (Compound No. 229),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-pyridin-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 230),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-pyridin-3-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 231),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-pyridin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 232),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-pyrazin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 233),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-pyrimidin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 234),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-1,2,4-triazin-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 235),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-1,3-thiazol-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 236),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-4H-1,2,4-triazol-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 237),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-2H-tetrazol-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 238),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-1H-tetrazol-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 239),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-pyrimidin-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 240),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-pyridin-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 241),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-pyridin-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 242),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-pyridin-3-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 243),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-pyridin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 244),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-pyrimidin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 245),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-pyrimidin-5-yl-1H-523 pyrazolo[3,4-b]pyridin-4-amine (Compound No. 246),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-1,2,4-triazin-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 247),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-1,3-thiazol-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 248),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-4H-1,2,4-triazol-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 249),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-2H-tetrazol-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 250),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-1H-tetrazol-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 251),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-pyridin-3-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 252),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-pyridin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 253),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-pyrimidin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 254),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-pyrimidin-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 255),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-1,2,4-triazin-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 256),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-1H-tetrazol-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 257),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-2H-tetrazol-5-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 258),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-4H-1,2,4-triazol-4-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 259),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-1,3-thiazol-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 260),

1-Ethyl-N-furan-3-yl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 261),

1-Ethyl-N-furan-3-yl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 262),

1-Ethyl-N-furan-3-yl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 263),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-pyrazin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 264),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-pyrazin-2-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 265),

7-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carbonitrile (Compound No. 266),

7-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylic acid (Compound No. 267),

Methyl 7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylate (Compound No. 268),

Ethyl 7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylate (Compound No. 269),

tert-Butyl 7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxylate (Compound No. 270),

7-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-N-methyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 271),

7-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-N-ethyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 272),

N-cyclopropyl-7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H -pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 273),

7-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 274),

7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-cyclopropyl-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 275),

N-cyclopropyl-7-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-ene-2-carboxamide (Compound No. 276),

1-Ethyl-5-(8-methoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 277),

5-(8-Ethoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 278),

N-cyclohexyl-5-(8-ethoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 279),

N-cyclohexyl-1-ethyl-5-(8-methoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 280),

3-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-N-ethyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 281),

N-cyclopropyl-3-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H -pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 282),

3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-cyclopropyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 283),

N-cyclopropyl-3-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 284),

N-ethyl-3-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 285),

3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-N-ethyl-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxamide (Compound No. 286),

Ethyl 3-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 287),

Methyl 3-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 288),

tert-Butyl 3-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 289),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-(8-methoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 290),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-5-(8-ethoxy-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 291),

1-Ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-N-1,2,4-triazin-3-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 292),

1-Ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-1,2,4-triazin-3-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 293),

1-Ethyl-5-(1-oxa-2-azaspiro[4.5]dec-2-en-3-yl)-N-1,2,4-triazin-3-yl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 294),

1-Ethyl-5-(2-methoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 295),

N-cyclohexyl-1-ethyl-5-(2-methoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 296),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-(2-methoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 297),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-5-(2-ethoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 298),

N-cyclohexyl-5-(2-ethoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 299),

5-(2-Ethoxy-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 300),

{7-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}methanol (Compound No. 301),

{7-{4-[(1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl)methanol (Compound No. 302),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-[2-(methoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 303),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-5-[2-(ethoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 304),

N-cyclohexyl-5-[2-(ethoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-1H-pyrazolo [3,4-b]pyridin-4-amine (Compound No. 305),

5-[2-(Ethoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-N-(tetrahydro-2H -pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 306),

1-Ethyl-5-[2-(methoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-N-(tetrahydro-2H -pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 307),

N-cyclohexyl-1-ethyl-5-[2-(methoxymethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo [3,4-b]pyridin-4-amine (Compound No. 308),

5-[2-(Aminomethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-N-cyclohexyl-1-ethyl-1H-pyrazolo [3,4-b]pyridin-4-amine (Compound No. 309),

5-[2-(Aminomethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1-ethyl-N-(tetrahydro-2H -pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 310),

5-[2-(Aminomethyl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-N-(1,1-dioxidotetrahydro -2H-thiopyran-4-yl)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 311),

N-[(7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl)methyl]acetamide (Compound No. 312),

N-[(7-{4-[(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl}-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl)methyl]propanamide (Compound No. 313),

N-({7-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}methyl)propanamide (Compound No. 314),

N-({7-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}methyl)propanamide (Compound No. 315),

N-({7-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}methyl)acetamide (Compound No. 316),

N-({7-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-5-oxa-6-azaspiro[3.4]oct-6-en-2-yl}methyl)acetamide (Compound No. 317),

1-Ethyl-N-(tetrahydro-2H-pyran-4-yl)-5-[2-(1H-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 318),

N-cyclohexyl-1-ethyl-5-[2-(1H-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo [3,4-b]pyridin-4-amine (Compound No. 319),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-[2-(1H-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 320),

1-Ethyl-N-(tetrahydro-2H-pyran-4-yl)-5-[8-(1H-tetrazol-5-yl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 321),

N-cyclohexyl-1-ethyl-5-[8-(1H-tetrazol-5-yl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo [3,4-b]pyridin-4-amine (Compound No. 322),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-[8-(1H-tetrazol-5-yl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 323),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-[8-(2H-tetrazol-5-yl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 324),

N-cyclohexyl-1-ethyl-5-[8-(2H-tetrazol-5-yl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo [3,4-b]pyridin-4-amine (Compound No. 325),

1-Ethyl-N-(tetrahydro-2H-pyran-4-yl)-5-[8-(2H-tetrazol-5-yl)-1-oxa-2-azaspiro[4.5]dec-2-en-3-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 326),

1-Ethyl-N-(tetrahydro-2H-pyran-4-yl)-5-[2-(2H-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 327),

N-cyclohexyl-1-ethyl-5-[2-(2H-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo [3,4-b]pyridin-4-amine (Compound No. 328),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-[2-(2H-tetrazol-5-yl)-5-oxa-6-azaspiro[3.4]oct-6-en-7-yl]-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 329),

Ethyl 3-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 330),

Ethyl 3-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 331),

Methyl 3-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 332),

Methyl 3-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 333),

tert-Butyl 3-[1-ethyl-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridin -5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 334),

tert-Butyl 3-[4-(cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-ene-8-carboxylate (Compound No. 335),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-(5-oxa-6-azaspiro[3.4]oct-6-en-7-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 336),

N-(1,1-dioxidotetrahydro-2H-thiopyran-4-yl)-1-ethyl-5-(1-oxa-2-azaspiro[4.4]non-2-en-3-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine (Compound No. 337),

3-[4-(Cyclohexylamino)-1-ethyl-1H-pyrazolo[3,4-b]pyridin-5-yl]-1-oxa-2-azaspiro[4.5]dec-2-en-8-amine (Compound No. 338),

or its pharmaceutically acceptable salts, pharmaceutically acceptable, stereoisomers, tautomers, or racemates, thereof.

3. A pharmaceutical composition comprising a therapeutically effective amount of a compound as defined in claim 1 along with one or more of pharmaceutically acceptable carriers, excipients or diluents.

4. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 , along with one or more of pharmaceutically acceptable carriers, excipients or diluents and at least one other compound selected fromβ2-agonists, corticosteroids, leukotriene antagonists, 5-lipoxygenase inhibitors, chemokine inhibitors, p38 kinase inhibitors, anticholinergics, antiallergics, PAF (platelet activating factor) antagonists, EGFR (epidermal growth factor receptor) kinase inhibitors, muscarinic receptor antagonists or combination(s) thereof.

5. A compound of claim 1 for use in a method for treating, inhibiting, or suppressing CNS diseases in a mammal.

6. A compound of claim 1 for use in a method for the treatment, inhibition, or suppression of rejection of transplant, rheumatoid arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), asthma, psoriasis, allergic rhinitis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, colitis, pancreatitis, and cancer in a mammal.

7. A pharmaceutical composition comprising a therapeutically effective amount of a compound as defined in claim 2 along with one or more of pharmaceutically acceptable carriers, excipients or diluents.

8. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 2 , along with one or more of pharmaceutically acceptable carriers, excipients or diluents and at least one other compound selected fromβ2-agonists, corticosteroids, leukotriene antagonists, 5-lipoxygenase inhibitors, chemokine inhibitors, p38 kinase inhibitors, anticholinergics, antiallergics, PAF (platelet activating factor) antagonists, EGFR (epidermal growth factor receptor) kinase inhibitors, muscarinic receptor antagonists or combination(s) thereof.

9. A compound of claim 2 for use in a method for treating, inhibiting, or suppressing CNS diseases in a mammal.

10. A pharmaceutical composition of claim 3 for use in a method for treating, inhibiting, or suppressing CNS diseases in a mammal.

11. A pharmaceutical composition of claim 4 for use in a method for treating, inhibiting, or suppressing CNS diseases in a mammal.

12. A compound of claim 2 for use in a method for the treatment, inhibition, or suppression of rejection of transplant, rheumatoid arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), asthma, psoriasis, allergic rhinitis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, colitis, pancreatitis, and cancer in a mammal.

13. A pharmaceutical composition of claim 3 for use in a method for the treatment, inhibition, or suppression of rejection of transplant, rheumatoid arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), asthma, psoriasis, allergic rhinitis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, colitis, pancreatitis, and cancer in a mammal.

14. A pharmaceutical composition of claim 4 for use in a method for the treatment, inhibition, or suppression of rejection of transplant, rheumatoid arthritis, bronchitis, chronic obstructive pulmonary disease (COPD), asthma, psoriasis, allergic rhinitis, shock, atopic dermatitis, eosinophilic granuloma, allergic conjunctivitis, osteoarthritis, colitis, pancreatitis, and cancer in a mammal.

Assignments (2)
MERGER Recorded Jan 13, 2016
From: RANBAXY LABORATORIES LIMTED
To: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Reel/Frame 037513/0475 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 13, 2009
From: RUDRA, SONALI; GUPTA, NIDHI; BAREGAMA, LALIT KUMAR; AGARWAL, RITU; KHAIRNAR, VINAYAK VASANTRAO; RAGHURAMIAH, MANDADAPU; PALLE, VENKATA P.; BALACHANDRAN, SARALA; KONDASKAR, ATUL; SALLA, MANOHAR; RAY, ABHIJIT; DASTIDAR, SUNANDA G.; VIJAYKRISHNAN, LALITHA
To: RANBAXY LABORATORIES LIMITED
Reel/Frame 023515/0827 →
Priority Claims (1)
IN 550/DEL/2007 · Mar 14, 2007 · national
Continuity (1)
Related Publication 20100292196A1 · Nov 18, 2010